Literature DB >> 6101203

In vitro splicing of the ribosomal RNA precursor of Tetrahymena: involvement of a guanosine nucleotide in the excision of the intervening sequence.

T R Cech1, A J Zaug, P J Grabowski.   

Abstract

In previous studies of transcription and splicing of the ribosomal RNA precursor in isolated Tetrahymena nuclei, we found that the intervening sequence (IVS) was excised as a unique linear RNA molecule and was subsequently cyclized. In the present work, transcription at low monovalent cation concentration is found to inhibit splicing and to lead to the accumulation of a splicing intermediate. This intermediate contains splicing activity that either is tightly bound to the RNA or is part of the RNA molecule itself. The intermediate is able to complete the excision of the IVS when it is incubated with a monovalent cation (75 mM (NH4)2SO4), a divalent cation (5-10 mM MgCl2) and a guanosine compound (1 microM GTP, GDP, GMP or guanosine). ATP, UTP, CTP and guanosine compounds without 2' and 3' hydroxyl groups are inactive in causing excision of the IVS. Accurate excision of the IVS, cyclization of the IVS and (apparently) ligation of the 26S rRNA sequences bordering the IVS all take place under these conditions, suggesting that a single activity is responsible for all three reactions. During excision of the IVS, the 3' hydroxyl of the guanosine moiety becomes linked to the 5' end of the IVS RNA via a normal phosphodiester bond. When GTP is used to drive the reaction, it is added intact without hydrolysis. Based on these results, we propose that Tetrahymena pre-rRNA splicing occurs by a phosphoester transferase mechanism. According to this model, the guanosine cofactor provides the free 3' hydroxyl necessary to initiate a series of three transfers that results in splicing of the pre-rRNA and cyclization of the excised IVS.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6101203     DOI: 10.1016/0092-8674(81)90390-1

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  191 in total

1.  Prebiotic synthesis of nucleotides.

Authors:  G Zubay; T Mui
Journal:  Orig Life Evol Biosph       Date:  2001 Feb-Apr       Impact factor: 1.950

Review 2.  Recent advances in the elucidation of the mechanisms of action of ribozymes.

Authors:  Y Takagi; M Warashina; W J Stec; K Yoshinari; K Taira
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

Review 3.  On the wobble GoU and related pairs.

Authors:  B Masquida; E Westhof
Journal:  RNA       Date:  2000-01       Impact factor: 4.942

Review 4.  Nuclease-resistant synthetic ribozymes: developing a new class of therapeutics.

Authors:  N Usman; L M Blatt
Journal:  J Clin Invest       Date:  2000-11       Impact factor: 14.808

5.  Homogeneous assays based on deoxyribozyme catalysis.

Authors:  M N Stojanovic; P de Prada; D W Landry
Journal:  Nucleic Acids Res       Date:  2000-08-01       Impact factor: 16.971

6.  Existence of efficient divalent metal ion-catalyzed and inefficient divalent metal ion-independent channels in reactions catalyzed by a hammerhead ribozyme.

Authors:  Jing-Min Zhou; De-Min Zhou; Yasuomi Takagi; Yasuhiro Kasai; Atsushi Inoue; Tadashi Baba; Kazunari Taira
Journal:  Nucleic Acids Res       Date:  2002-06-01       Impact factor: 16.971

7.  Anti-viral activity of hairpin ribozyme directed against HBV core region in vitro.

Authors:  J Lin; Y Song; X Kong; N Xie; X Wu; N Liu; N Wang; E Cao; Y Jin
Journal:  J Tongji Med Univ       Date:  2001

Review 8.  From records to self-description: the role played by RNA in early evolutive systems.

Authors:  A Moreno Bergareche; J Fernández Ostolaza
Journal:  Acta Biotheor       Date:  1992-03       Impact factor: 1.774

Review 9.  Evolutionary conservation of reactions in translation.

Authors:  M Clelia Ganoza; Michael C Kiel; Hiroyuki Aoki
Journal:  Microbiol Mol Biol Rev       Date:  2002-09       Impact factor: 11.056

Review 10.  Themes and variations in riboswitch structure and function.

Authors:  Alla Peselis; Alexander Serganov
Journal:  Biochim Biophys Acta       Date:  2014-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.